A man surfing

Founder & CTO · University of Warwick

Professor Nigel Stocks

Engineer, physicist, and three-decade pioneer in neural signal processing — the scientist behind the RULPS technology that makes Sonotu possible.

Sonotu medical device research and hearing technology

Title

Title

Director of the Neural and Stochastic processing lab

Institution

University of Warwick Engineering

Education

BSc Applied Physics & Electronics; PhD Stochastic Nonlinear Dynamics

Recognition

Listed in Stanford/Elsevier World’s Top 2% Scientists every year since 2019

Nigel’s career has been defined by a single obsession: understanding how biological sensory systems process signals in noise — and using that understanding to build better technology. His work on suprathreshold stochastic resonance and cochlear implant technology placed him at the intersection of neuroscience, signal processing, and medical devices long before it became fashionable.

“The fundamental question was always the same: how do you extract useful signal from a noisy, resource-constrained system?”

“The fundamental question was always the same: how do you extract useful signal from a noisy, resource-constrained system?”

— Prof Nigel Stocks, Founder & CTO, Sonotu

About Us

Building the Future of Affordable Hearing Accessibility.

Sonotu medical device research and hearing technology

Why Choose Us?

Traditional hearing technology remains financially inaccessible for millions across emerging healthcare systems.

Sonotu was created to help bridge that gap through affordability-focused engineering, scalable healthcare accessibility, and research-driven innovation.

Our goal is not simply to build hearing devices.

It is to help create a future where hearing accessibility is no longer limited by geography, infrastructure, or income.

Research-Driven Innovation

Emerging Market Focus

Scalable Accessibility Vision

Beyond Hearing Technology

Hearing accessibility is more than a medical challenge. It affects education, communication, employment, healthcare inclusion, and quality of life for millions worldwide. At Sonotu, we believe affordable hearing technology has the potential to unlock greater accessibility, independence, and opportunity across underserved communities.

Expanding Accessibility

Supporting Inclusion

Building for Scale

Sonotu medical device research and hearing technology

Our Philosophy

We believe the future of hearing healthcare must be: accessible, scalable, and globally inclusive. Sonotu is building toward that future.

0B +

0B +

People affected by hearing loss globally

0%

0%

Unmet hearing aid demand in low-income regions

0x Lower

0x Lower

Compared to traditional hearing technologies

Progress & Regulatory Readiness

Tailored guidance across the core areas that drive sustainable success.

01

2018

Proof of Concept

Initial concept validation showing the feasibility of delivering affordable hearing technology for underserved populations.

Card Glow background

02

2019

Prototype Development

Development of early prototypes focused on affordability, usability, and performance.

Card Glow background

03

2020

Clinical Audiology (UK)

Clinical collaboration and audiology validation activities conducted in the United Kingdom.

Card Glow background

04

2021

Local Clinical Trials

Early-stage clinical testing and user validation to assess performance in real-world environments.

Card Glow background

05

2022

Commercial Prototypes & Sonotu UK incorporated

Establishment of the company's commercial and operational foundation.

Card Glow background

06

2023

Market Testing

Pilot deployments and market validation activities to better understand customer and stakeholder requirements.

Card Glow background

07

2024

Commercial Prototypes

Refinement of production-ready devices and manufacturing preparation.

Card Glow background

08

2025

Gen 1+ Development

Development of next-generation platform enhancements, including automated fitting and expanded accessibility features.

Card Glow background

09

2026

Gen 1 Product Launch

Commercial launch of Sonotu's first-generation hearing solution.

Card Glow background

REGULATORY SECTION

Establishing the certifications, registrations, and approvals required for scalable market deployment.

01

Sonotu India Incorporated

Corporate entity established to support operations, manufacturing, distribution, and commercial growth within India.

02

ISO 13485:2016 Certified

Certified quality management system for medical device development and manufacturing.

03

CDSCO Medical Device License

Medical device licensing pathway established for commercial deployment in India. MD-6 application currently under process.

04

Import & Distribution Readiness

Established operational infrastructure including: GST Registration Import Export Code (IEC) Authorised Dealer Code Legal Metrology Registration MSME Registration

05

Environmental Compliance

Extended Producer Responsibility (EPR) registration covering plastics and batteries.

06

Financial & Operational Infrastructure

Professional tax registration, company tax registration, banking infrastructure, and commercial operations established.

Medical technology research and hearing accessibility
Medical technology research and hearing accessibility
AI hearing technology and clinical product development

FAQs

Got Questions?

Answers for clinicians, partners, and investors evaluating Sonotu’s hearing technology platform.

How does Sonotu’s hearing technology work?

Is the technology clinically validated?

What is Sonotu’s regulatory pathway?

Does Sonotu manufacture its own devices?

How can healthcare partners work with Sonotu?